Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2213 of 5804
-
Virtual workouts may protect heart health in breast cancer patients on chemo
Symptom relief Recruiting nowThis clinical trial studies whether a healthy living intervention (HLI), with or without a physical activity intervention (PAI), helps maintain the ability to exercise, heart health, and quality of life in breast cancer patients who are scheduled to receive chemotherapy treatment…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can a simple exercise trick boost hamstring strength in young pole vaulters?
Symptom relief Recruiting nowThe purpose of this randomized controlled trial is to compare the effects of Nordic Hamstring Exercise (NHE) and Blood Flow Restriction-assisted Nordic Hamstring Exercise (BFR-NHE) on hamstring muscle strength, muscle morphology, and functional performance in elite adolescent fem…
Phase: NA • Sponsor: Toros University • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
New Blood-Thinner strategy aims to cut bleeding after heart device implants
Disease control Not yet recruitingThis is a multi-center, prospective, open-label, randomized controlled trial (STEP-AF) designed to evaluate the safety of a stepwise anticoagulation strategy compared with the guideline-recommended standard anticoagulation regimen in patients with non-valvular atrial fibrillation…
Phase: NA • Sponsor: Fu Wai Hospital, Beijing, China • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a laser beam ease the pain of Ehlers-Danlos syndrome?
Symptom relief Recruiting nowThis study evaluates the effect of photobiomodulation (PBM) therapy using a MLS® class IV laser on chronic pain and fatigue in patients with hypermobile Ehlers-Danlos Syndrome (hEDS). hEDS is a hereditary connective tissue disorder characterized by joint hypermobility, chronic pa…
Sponsor: Centre Medical ISM (Integrative Systemic Medicine) • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Heart patients get a buddy: new study tests peer support for AF anxiety
Symptom relief Recruiting nowThe goal of this randomized clinical trial is to evaluate whether a peer-mentor intervention can improve mental well-being among vulnerable patients with atrial fibrillation (AF). Patients with AF often experience anxiety, uncertainty, and reduced quality of life. These challenge…
Phase: NA • Sponsor: University College Copenhagen • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Leg workout beats arm workout for gestational diabetes?
Disease control Recruiting nowThe current study is a single-blind, parallel-group randomized controlled trial involving 108 participants with diabetes during pregnancy. The trial will compare leg ergometer with arm ergometer. Interventions will be delivered three times per week for eight weeks. The primary ou…
Phase: NA • Sponsor: Lahore University of Biological and Applied Sciences • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could your voice reveal chronic fatigue syndrome? mayo clinic launches study
Diagnosis Recruiting nowThe purpose of this research is to evaluate the use of a voice-based tool in the diagnosis and management of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 12:38 UTC
-
Can a common heart drug shield breast cancer patients from Surgery-Related heart damage?
Disease control Not yet recruitingThis study aims to evaluate the impact of using propranolol, a non-selective beta-blocker, on preventing myocardial injury after non-cardiac surgery (MINS) in breast cancer patients who also have hypertension or angina. Stress from surgery and anesthesia can increase sympathetic …
Phase: PHASE4 • Sponsor: Chang-Ik Yoon • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Smartphone app listens for heart defects – no stethoscope needed
Diagnosis ENROLLING_BY_INVITATIONThis observational study aims to assess the performance of the software called ausculto™. ausculto™ is a collection of computer algorithms that intend to analyse heart sounds recorded from the built-in microphone of a smartphone for abnormal sounds. Participants will have their …
Sponsor: The University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
Arthritis drug may double as migraine relief
Symptom relief Not yet recruitingMigraine affects approximately 15% of the global population. Its prevalence doubles or even triples in individuals with chronic inflammatory conditions, such as chronic inflammatory rheumatic diseases (34%), multiple sclerosis (MS) (46%), or endometriosis (35%). The prevalence of…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
New ER procedure could ease sciatica pain in minutes
Symptom relief Recruiting nowThe goal of this clinical trial is to compare transgluteal sciatic nerve block to standard of care to treat sciatic back pain in adult patients who present to the emergency department. The main question it aims to answer is: Is a transgluteal sciatic nerve block better than stan…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
New eczema ointment shows promise in early trial
Symptom relief Recruiting nowThis study is a randomized, double-blind, placebo-controlled, multicenter Phase Ib/II clinical study designed to evaluate the efficacy, safety, and PK characteristics of HL-300 ointment with different concentration regimens for mild-to-moderate AD.
Phase: PHASE1, PHASE2 • Sponsor: Hangzhou Highlightll Pharmaceutical Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
New antibody drug takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThe primary purpose of this study is to evaluate safety and tolerability profile of EMB-15, identify the recommended Phase 2 dose(s) (RP2Ds) for EMB-15. Pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity, and the anti-tumor activity of EMB-15 will also be assessed.
Phase: PHASE1 • Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Free produce and coaching aim to stop diabetes before it starts
Prevention Recruiting nowType 2 Diabetes remains a major chronic disease among adults in the United States. A way to prevent Type 2 Diabetes is to engage in a diabetes prevention program. In the diabetes prevention program, individuals at risk of Type 2 Diabetes meet with a health coach to learn effectiv…
Phase: NA • Sponsor: Virginia Commonwealth University • Aim: Prevention
Last updated Jun 27, 2026 13:03 UTC
-
AI writing coach aims to ease teen grief in landmark trial
Symptom relief Not yet recruitingProlonged Grief Disorder (PGD) is a severe, disabling condition characterized by intense yearning and difficulty accepting the reality of loss, which significantly impairs the academic and psychosocial functioning of bereaved adolescents. While Grief-Focused Cognitive Behavioral …
Phase: NA • Sponsor: Peking University • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
One-Time immune boost for ARID1A-Mutant cancers?
Disease control Recruiting nowThis is a proof of principle clinical trial determining efficacy of single dose dualimmune checkpoint inhibitors to increase intra-tumoral T cells in esophageal, gastroesophageal junction, and gastric adenocarcinomas. These are subjects who have not previously been treated for th…
Phase: EARLY_PHASE1 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New hope for leprosy patients: experimental drug dovramilast under trial
Disease control Recruiting nowDovramilast has not been approved for leprosy type 2 reaction (erythema nodosum leprosum, ENL) or any other disease anywhere in the world. In this study, an experimental drug called dovramilast is being tested to see how it compares to current treatments for leprosy type 2 reacti…
Phase: PHASE2 • Sponsor: Medicines Development for Global Health • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Virtual reality or core workouts: which eases back pain better?
Symptom relief OngoingNon-specific low back pain (NSLBP) is a prevalent musculoskeletal disorder. (Maher et al., 2017). Globally, 60%-80% of adults' experience low back pain, with 10% developing chronic forms, of which 85% are classified as chronic nonspecific low back pain without a clear etiology. (…
Phase: NA • Sponsor: Emad Eldin Mohamed • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Could a zap to your face lift your mood? new trial explores FES for depression
Symptom relief Not yet recruitingThis study aims to determine whether Functional Electrical Stimulation (FES) of the facial muscles is a safe and effective treatment for major depressive disorder (MDD).
Phase: NA • Sponsor: Unity Health Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Pilot study tests creatine and exercise to save muscle during GLP-1 weight loss
Disease control Recruiting nowGLP-1 receptor agonists are effective for weight loss, but significant muscle mass is lost as a proportion of this weight loss. This study combines resistance-training and creatine supplementation to try to prevent this loss of muscle mass.
Phase: NA • Sponsor: University of Saskatchewan • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC